The GLP-1 ID approach combines individualized dosing with ongoing provider support, health coaching, and community connection, creating a comprehensive care model that delivers results
Semaglutide can also lead to similar issues but may be milder for some users
The American Journal of Medicine, 119(12), 1005- 1012
They can prescribe the best dose for you based on your health goals and previous response to GLP-1s, which may be a starting dose of 2.5 mg or 5 mg of tirzepatide
Shapsis notes that patients whose primary goal is weight loss , and who qualify medically, typically achieve better and more predictable results with Wegovy
And it is pretty significant: Studies show that the average person will lose around 5 percent of their weight after three months